Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Check out the Smoke & Mirrors Update Launch Trailer for New Arc Line, a tactical strategy steampunk RPG developed by Dreamate. Players can look out for new content with the first major Smoke & Mirrors ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Most genes are ancient and shared across species. But a small subset of genes are relative newcomers, spontaneously emerging from stretches of DNA that once encoded nothing at all.

Background Immune-mediated processes leading to childhood type 1 diabetes may begin in fetal life. We hypothesised that a ...

A new study investigates the link between processed meat, sugar-sweetened beverages, and trans fatty acids, to diseases such ...

In response, Novo is reorganizing its leadership team following the surprise ouster of Chief Executive Lars Fruergaard Jorgensen. Other key executives had already stepped down, including U.S. chief ...

Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new weight-loss treatment.

Novo Nordisk reveals three new weight loss drugs, aiming to offer diverse options for obesity and weight management.

By designing proteins de novo scientists can more efficiently create novel therapeutics tailored for specific biological functions.